BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21876728)

  • 1. Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses.
    Sullivan M; Kaur K; Pauli N; Wilson PC
    F1000 Biol Rep; 2011; 3():17. PubMed ID: 21876728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics.
    Dalziel M; Beers SA; Cragg MS; Crispin M
    Glycobiology; 2018 Sep; 28(9):697-712. PubMed ID: 29800150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling COVID-19 with neutralizing monoclonal antibodies.
    Corti D; Purcell LA; Snell G; Veesler D
    Cell; 2021 Jun; 184(12):3086-3108. PubMed ID: 34087172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics.
    Sorieul C; Papi F; Carboni F; Pecetta S; Phogat S; Adamo R
    Pharmacol Ther; 2022 Jul; 235():108158. PubMed ID: 35183590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antibody technology and the development of antibodies against cytomegalovirus.
    Ohlin M; Söderberg-Nauclér C
    Mol Immunol; 2015 Oct; 67(2 Pt A):153-70. PubMed ID: 25802091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic and their immunological aspects: Current treatment strategies and agents.
    Jain M; Mishra A; Singh MK; Shyam H; Kumar S; Shankar P; Singh S
    Natl J Maxillofac Surg; 2022; 13(3):322-329. PubMed ID: 36683928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new dawn for monoclonal antibodies against antimicrobial resistant bacteria.
    Troisi M; Marini E; Abbiento V; Stazzoni S; Andreano E; Rappuoli R
    Front Microbiol; 2022; 13():1080059. PubMed ID: 36590399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding immunosenescence to improve responses to vaccines.
    Goronzy JJ; Weyand CM
    Nat Immunol; 2013 May; 14(5):428-36. PubMed ID: 23598398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antigenome: from protein subunit vaccines to antibody treatments of bacterial infections?
    Giefing C; Nagy E; von Gabain A
    Adv Exp Med Biol; 2009; 655():90-117. PubMed ID: 20047038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of neonates: problem and issues.
    Hodgins DC; Shewen PE
    Vaccine; 2012 Feb; 30(9):1541-59. PubMed ID: 22189699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeutics.
    Ritu ; Chandra P; Das A
    Clin Exp Med; 2023 Dec; 23(8):4297-4322. PubMed ID: 37804358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homogeneously modified immunoglobulin domains for therapeutic application.
    Liu T; Du J; Luo X; Schultz PG; Wang F
    Curr Opin Chem Biol; 2015 Oct; 28():66-74. PubMed ID: 26117722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When binding is enough: nonactivating antibody formats.
    Labrijn AF; Aalberse RC; Schuurman J
    Curr Opin Immunol; 2008 Aug; 20(4):479-85. PubMed ID: 18577454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into human immune memory from SARS-CoV-2 infection and vaccination.
    Hartley GE; Edwards ESJ; O'Hehir RE; van Zelm MC
    Allergy; 2022 Dec; 77(12):3553-3566. PubMed ID: 36048132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibody screening using glycan arrays.
    Marglous S; Brown CE; Padler-Karavani V; Cummings RD; Gildersleeve JC
    Chem Soc Rev; 2024 Mar; 53(5):2603-2642. PubMed ID: 38305761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies as diagnostics; an appraisal.
    Siddiqui MZ
    Indian J Pharm Sci; 2010 Jan; 72(1):12-7. PubMed ID: 20582184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases.
    Xu Z; Patel A; Tursi NJ; Zhu X; Muthumani K; Kulp DW; Weiner DB
    Front Med Technol; 2020; 2():571030. PubMed ID: 35047878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies and Selection of Monoclonal Antibodies.
    Hanack K; Messerschmidt K; Listek M
    Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.